Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
Items 801–900 of 1,004
Brugger, N., Lichtblau, M., Maeder, M. T., Müller, H., Pellaton, C., Yerly, P., & Swiss Society For Pulmonary Hypertension Ssph (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.20486 · Cited by 23
Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit
Jentzer, J. C., Wiley, B. M., Reddy, Y. N. V., Barnett, C. F., Borlaug, B. A., & Solomon, M. A. (2021) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuab127 · Cited by 23
Connective Tissue Disease–Associated Interstitial Lung Disease
Antin-Ozerkis, D. E., & Hinchcliff, M. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.05.008 · Cited by 23
Pulmonary arterial hypertension with below threshold pulmonary vascular resistance
Ratwatte, S., Anderson, J., Strange, G. A., Corrigan, C., Collins, N. J., Celermajer, D. S., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01654-2019 · Cited by 23
Self-citationPost–Pulmonary Embolism Syndrome—A Diagnostic Dilemma and Challenging Management
Shah, K. P., Lee, C., McBane, R. D., Piazza, G., Frantz, R. P., Houghton, D. E., Casanegra, A. I., & Henkin, S. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.07.008 · Cited by 22
Pulmonary Hypertension Due to Left Heart Disease—A Practical Approach to Diagnosis and Management
Lee, F., & Mielniczuk, L. M. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.11.003 · Cited by 22
d’Humières, T., Savale, L., Inamo, J., Deux, J., Deswarte, S., Lionnet, F., Loko, G., Chantalat, C., Damy, T., Guillet, H., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26271 · Cited by 22
Vinke, P., Koudstaal, T., Muskens, F., van den Bosch, A. E., Balvers, M. G. J., Poland, M., Witkamp, R. F., van Norren, K., & Boomars, K. A. (2021) · Nutrients · doi:10.3390/nu13113923 · Cited by 22
Risk Factors of Pulmonary Hypertension in Patients on Hemodialysis: A Single Center Study
Nagaraju, S. P., Bhojaraja, M. V., Paramasivam, G., Prabhu, R., Rangaswamy, D., Rao, I. R., & Shenoy, S. V. (2021) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s346184 · Cited by 22
Saunders, H., Helgeson, S. A., Abdelrahim, A., Rottman-Pietrzak, K., Reams, V., Zeiger, T. K., Moss, J. E., & Burger, C. D. (2022) · Diseases · doi:10.3390/diseases10010005 · Cited by 22
Raza, F., Dharmavaram, N. L., Hess, T., Dhingra, R., Runo, J. R., Chybowski, A., Kozitza, C. J., Batra, S., Horn, E. M., Chesler, N. C., et al. (2022) · Clinical Cardiology · doi:10.1002/clc.23831 · Cited by 22
Upton, P. D., Dunmore, B. J., Li, W., & Morrell, N. W. (2022) · Developmental Dynamics · doi:10.1002/dvdy.478 · Cited by 22
Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
Redel‐Traub, G., Sampson, K. J., Kass, R. S., & Bohnen, M. S. (2022) · Biomolecules · doi:10.3390/biom12101341 · Cited by 22
Puigrenier, S., Giovannelli, J., Lamblin, N., de Groote, P., Fertin, M. J., Bervar, J.-F., Lamer, A., Edmé, J., Balquet, M.-H., Sobanski, V., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02205-4 · Cited by 22
Zhang, N., Zhao, X., Li, J., Huang, L., Li, H., Feng, H., Garcia, M. A., Cao, Y., Sun, Z., & Chai, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041297 · Cited by 22
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
Alamri, A. K., Ma, C. L., & Ryan, J. J. (2023) · Drugs · doi:10.1007/s40265-023-01862-z · Cited by 22
Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
Jin, Q., Chen, D., Zhang, X., Zhang, F., Zhong, D., Lin, D., Guan, L., Pan, W., Zhou, D., & Ge, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061579 · Cited by 22
Park, S. M., Lee, S. Y., Jung, M., Youn, J., Kim, D., Cho, J. Y., Cho, D., Hyun, J., Cho, H., Park, S., et al. (2023) · International Journal of Heart Failure · doi:10.36628/ijhf.2023.0016 · Cited by 22
Lachant, D. J., Light, A., Lachant, M., Annis, J. S., Hemnes, A. R., Brittain, E. L., & White, R. J. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12285 · Cited by 22
Stem cell therapy in pulmonary hypertension: current practice and future opportunities
Zheng, R., Xu, T., Wang, X., Yang, L., Wang, J., & Huang, X. (2023) · European Respiratory Review · doi:10.1183/16000617.0112-2023 · Cited by 22
Pulmonary hypertension – the latest updates for physicians
Virsinskaite, R., Karia, N., Kotecha, T., Schreiber, B. E., Coghlan, G., & Knight, D. S. (2023) · Clinical Medicine · doi:10.7861/clinmed.2023-23.5.cardio4 · Cited by 22
Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
Haynes, Z. A., Chandel, A., & King, C. S. (2023) · Cells · doi:10.3390/cells12192394 · Cited by 22
Chen, Y.-X., Deng, Z., Xue-Gao, Qiang-Du, Juan-Yin, Chen, G., Li, J., Zhao, Y.-M., Zhang, H., Zhang, G., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115816 · Cited by 22
Management of Pulmonary Arterial Hypertension: Current Strategies and Future Prospects
Sharma, M., Paudyal, V., Syed, S., Thapa, R., Kassam, N., & Surani, S. (2025) · Life · doi:10.3390/life15030430 · Cited by 22
Oxidation of PKGIα mediates an endogenous adaptation to pulmonary hypertension
Rudyk, O., Rowan, A., Prysyazhna, O. D., Krasemann, S., Hartmann, K., Zhang, M., Shah, A. M., Ruppert, C., Weiß, A., SCHERMULY, R. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904064116 · Cited by 22
Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives
Dimitroglou, Y., Aggeli, C., Alexopoulou, A. A., Mavrogeni, S. I., & Tousoulis, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122132 · Cited by 22
Christiansen, D. L., Porter, S., Hurlburt, L., Weiss, A. J., Granton, J. T., & Wentlandt, K. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.11.023 · Cited by 22
Imaging of Chronic Thromboembolic Disease
Haramati, A., & Haramati, L. B. (2020) · Lung · doi:10.1007/s00408-020-00344-3 · Cited by 22
Methods to improve the yield of right heart catheterization in pulmonary hypertension
Arunachalam, A., Chaisson, N. F., & Tonelli, A. R. (2020) · Respiratory Medicine X · doi:10.1016/j.yrmex.2020.100015 · Cited by 22
Ibe, T., Wada, H., Sakakura, K., Ugata, Y., Maki, H., Yamamoto, K., Seguchi, M., Taniguchi, Y., Jinnouchi, H., Momomura, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247987 · Cited by 22
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification
Oldham, W. M., Hemnes, A. R., Aldred, M. A., Barnard, J., Brittain, E. L., Chan, S. Y., Cheng, F., Cho, M. H., Desai, A. A., Garcia, J. G. N., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.056 · Cited by 22
Kažukauskienė, I., Balčiūnaitė, G., Baltrūnienė, V., Čelutkienė, J., Maneikienė, V. V., Čibiras, S., Ručinskas, K., & Grabauskienė, V. (2021) · Cardiovascular Ultrasound · doi:10.1186/s12947-021-00254-1 · Cited by 22
Chen, D., Zhang, H.-F., Yuan, T., Sun, S., Wang, R., Wang, S., Fang, L., Lyu, Y., & Du, G. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00865-y · Cited by 22
The ever-expanding phenotypical spectrum of human TBX4 mutations: from toe to lung
Haarman, M. G., Kerstjens‐Frederikse, W. S., & Berger, R. M. F. (2019) · European Respiratory Journal · doi:10.1183/13993003.01504-2019 · Cited by 22
Austin, E. D., & Elliott, C. G. (2020) · European Respiratory Journal · doi:10.1183/13993003.00585-2020 · Cited by 22
Genuardi, M. V., Shpilsky, D., Handen, A. L., Vanspeybroeck, G., Canterbury, A., Lu, M., Shapero, K. S., Nieves, R. A., Thoma, F. W., Mulukutla, S. R., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018394 · Cited by 21
GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease
Chen, Z., Zhang, J., Wei, D., Chen, J., & Yang, J. (2021) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484211015535 · Cited by 21
Lung transplantation for pulmonary hypertension
Hwalek, A. E., Rosenheck, J. P., & Whitson, B. A. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-20 · Cited by 21
Critical care management of the patient with pulmonary hypertension
Barnett, C. F., O’Brien, C., & Marco, T. D. (2021) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuab113 · Cited by 21
Fayyaz, A. U., Sabbah, M. S., Dasari, S., Griffiths, L. G., DuBrock, H. M., Wang, Y., Charlesworth, M. C., Borlaug, B. A., Jenkins, S. M., Edwards, W. D., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac005 · Cited by 21
Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease
Cook, D. P., Xu, M., Martucci, V. L., Annis, J. S., Aldrich, M. C., Hemnes, A. R., & Brittain, E. L. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12006 · Cited by 21
Croquette, M., Puyade, M., Montani, D., Jutant, E., Géa, M. D., Lanéelle, D., Thollot, C., & Trihan, J.-E. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10276-3 · Cited by 21
Self-citationInduction of GLI1 by miR-27b-3p/FBXW7/KLF5 pathway contributes to pulmonary arterial hypertension
Wang, Q., Chai, L., Zhang, Q., Wang, J., Liu, J., Chen, H., Wang, Y., Chen, Y., Shen, N., Xie, X., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.06.012 · Cited by 21
Yarlas, A. S., Mathai, S. C., Nathan, S. D., DuBrock, H. M., Morland, K., Anderson, N., Kosinski, M. R., Lin, X., & Classi, P. M. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.08.2206 · Cited by 21
Wang, J., Liu, H., Jing, Z., Zhao, F., & Zhou, R. (2022) · The Chinese Journal of Physiology · doi:10.4103/0304-4920.354801 · Cited by 21
Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis
Nihtyanova, S. I., Schreiber, B. E., Ong, V. H., Wells, A. U., Coghlan, G., & Denton, C. P. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42349 · Cited by 21
Self-citationPulmonary vascular disease as a complication of pediatric congenital heart diseases
Wacker, J., Joye, R., Genecand, L., Lador, F., & Beghetti, M. (2023) · Translational Pediatrics · doi:10.21037/tp-23-64 · Cited by 21
Insights into Endothelin Receptors in Pulmonary Hypertension
Liu, R., Yuan, T., Wang, R., Gong, D., Wang, S., Du, G., & Fang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210206 · Cited by 21
Singh, H., Agarwal, L., Jani, C., Bhatt, P. S., Hartley, A., Shalhoub, J., Kurman, J. S., Omari, O. A., Ahmed, A., Marshall, D. C., et al. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-1468 · Cited by 21
Lu, G., Du, R., Liu, Y., Zhang, S., Li, J., & Pei, J. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s429535 · Cited by 21
The double-edged sword effect of indigo naturalis
Xu, Y., Lin, C., Tan, H., & Bian, Z. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114476 · Cited by 21
RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension
Wang, Z., Zhang, Y., Shi, J.-Z., Yi, Y., Zhao, L.-L., Kou, J., He, Y., Xie, X., Zhang, S.-J., & Pang, X. (2024) · Hypertension Research · doi:10.1038/s41440-024-01607-9 · Cited by 21
Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension
Miranda, A. C., Cornelio, C. K., Tran, B. A., & Fernandez, J. (2025) · Journal of Pharmacy Technology · doi:10.1177/87551225251317957 · Cited by 21
Maleszewski, J. J., Burke, A. P., Veinot, J. P., & Edwards, W. D. (2023) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477299-ch20 · Cited by 21
Pulmonary capillary surface area in supine exercising humans: demonstration of vascular recruitment
Langleben, D., Orfanos, S. E., Giovinazzo, M., Schlesinger, R. D., Naeije, R., Fox, B. D., Abualsaud, A. O., Blenkhorn, F., Rudski, L., & Catravas, J. D. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00098.2019 · Cited by 21
Enfermedad tromboembólica crónica pulmonar
Ramírez, P., Otero, R., & Barberà, J. A. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.10.027 · Cited by 21
Keller, S. P. (2020) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2019.12.03 · Cited by 21
Congenital Heart Disease and Pulmonary Hypertension
Constantine, A. H., Dimopoulos, K., & Opotowsky, A. R. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.04.008 · Cited by 21
Hemodynamics in Adults With the Shone Complex
Jain, C. C., Warnes, C. A., Egbe, A. C., Cetta, F., DuBrock, H. M., Connolly, H. M., & Miranda, W. R. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.06.024 · Cited by 21
Li, Q., Meng, L., & Liu, D. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00782 · Cited by 21
Lichtblau, M., Saxer, S., Latshang, T. D., Aeschbacher, S. S., Huber, F. L., Scheiwiller, P. M., Herzig, J. J., Schneider, S., Hasler, E., Furian, M., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00502 · Cited by 21
Pussadhamma, B., Tipparot, T., Chaosuwannakit, N., Mahakkanukrauh, A., Suwannaroj, S., Nanagara, R., & Foocharoen, C. (2020) · International Journal of Rheumatology · doi:10.1155/2020/8884442 · Cited by 21
Walsh, T. P., Baird, G. L., Atalay, M. K., Agarwal, S., Arcuri, D., Klinger, J. R., Mullin, C. J., Morreo, H., Normandin, B., Shiva, S., et al. (2021) · Pulmonary Circulation · doi:10.1177/2045894021989554 · Cited by 21
Varghese, N. P., Tillman, R. H., & Keller, R. L. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25258 · Cited by 21
Olschewski, H. (2021) · Diagnostics · doi:10.3390/diagnostics11020311 · Cited by 21
Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype
Oldham, W. M., Hess, E., Waldo, S. W., Humbert, M. J. C., Choudhary, G., & Maron, B. A. (2021) · European Respiratory Journal · doi:10.1183/13993003.04625-2020 · Cited by 21
Invasive Hemodynamic and Metabolic Evaluation of HFpEF
Finet, J. E., Iterson, E. H. V., & Tang, W. H. W. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00904-7 · Cited by 21
State-of-the-art MR Imaging for Thoracic Diseases
Tanaka, Y., Ohno, Y., Hanamatsu, S., Obama, Y., Ueda, T., Ikeda, H., Iwase, A., Fukuba, T., Hattori, H., Murayama, K., et al. (2021) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.rev.2020-0184 · Cited by 21
Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes
Kostyunina, D. S., & McLoughlin, P. (2021) · Antioxidants · doi:10.3390/antiox10050779 · Cited by 21
Fabro, A. T., Rúgolo, J. R. M., Baldavira, C. M., Prieto, T. G., Farhat, C., Mangone, F. R., Batah, S. S., Cruvinel, H. R., Aldá, M. A., Monteiro, J. S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648769 · Cited by 21
Promising therapeutic approaches in pulmonary arterial hypertension
Ali, M. K., Ichimura, K., & Spiekerkoetter, E. F. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.05.003 · Cited by 21
Appenzeller, P., Lichtblau, M., Berlier, C., Aubert, J., Azzola, A., Fellrath, J., Geiser, T., Lador, F., Pohle, S., Opitz, I., et al. (2021) · Pulmonary Circulation · doi:10.1002/pul2.12001 · Cited by 21
Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis
Zhang, S., Tong, X., Zhang, T., Wang, D., Liu, S., Wang, L., & Fan, H. X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.809594 · Cited by 21
DuBrock, H. M., del Valle, K. T., & Krowka, M. J. (2022) · Liver Transplantation · doi:10.1002/lt.26422 · Cited by 21
Self-citationPrevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis
Slivnick, J. A., Zaręba, K. M., Varghese, J., Truong, V. T., Wallner, A. L., Tong, M., Hummel, C., Mazur, W. M., & Rajpal, S. (2022) · Open Heart · doi:10.1136/openhrt-2021-001808 · Cited by 21
Oliveira, S. D. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316236 · Cited by 21
Zhao, J., Wang, Q., Deng, X., Qian, J., Tian, Z., Liu, Y., Li, M., & Zeng, X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108192 · Cited by 21
Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension
Naranjo, M., Mercurio, V., Hassan, H. J., Alturaif, N., Cuomo, A., Attanasio, U., Diab, N., Sahetya, S. K., Mukherjee, M., Hsu, S., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00002-2022 · Cited by 21
Lung transplantation in HIV-positive patients: a European retrospective cohort study
Rouzaud, C., Berastegui, C., Picard, C., Vos, R., Savale, L., Demant, X., Bertani, A., Verschuuren, E. A. M., Jaksch, P., Reed, A. K., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00189-2022 · Cited by 21
Potential role of cellular senescence in pulmonary arterial hypertension
Liu, L., Wei, Y., Giunta, S., He, Q., & Xia, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13696 · Cited by 21
Bajwa, E. K., Cislak, D., Palcza, J. S., Feng, H.-P., Messina, E. J., Reynders, T., Denef, J., Vasile, C., Lai, E., & Stoch, S. A. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.107065 · Cited by 21
From acute SARS-CoV-2 infection to pulmonary hypertension
Egom, E. E. A., Shiwani, H. A., & Nouthé, B. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1023758 · Cited by 21
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
Tennøe, A. H., Murbræch, K., Andreassen, J. C., Fretheim, H., Midtvedt, Ø., Garen, T., Dalen, H., Gude, E., Andreassen, A., Aakhus, S., et al. (2019) · ACR Open Rheumatology · doi:10.1002/acr2.1037 · Cited by 21
Management of pulmonary arterial hypertension in patients aged over 65 years
Sitbon, O., & Howard, L. (2019) · European Heart Journal Supplements · doi:10.1093/eurheartj/suz206 · Cited by 21
Mulvaney, E. P., Reid, H. M., Bialešová, L., Mendes‐Ferreira, P., Adão, R., Brás‐Silva, C., & Kinsella, B. T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173658 · Cited by 21
International Journal of Angiology
Lukito, V. A. D. S. S. R. L. M. R. A. A. A. (2026) · International Journal of Angiology · doi:10.1055/s-00000167 · Cited by 21
Fundamental and Targeted Approaches in Pulmonary Arterial Hypertension Treatment
Park, J. S., Choi, Y. H., Min, J.-Y., Lee, J., & Shim, G. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020224 · Cited by 20
The Etiology and Management of Critical Acute Right Heart Failure
Luk, A. C., Teijeiro‐Paradis, R., Kochan, A., Billia, F., Douflé, G., Magder, S. A., Mendelson, A. A., McGuinty, C., & Granton, J. T. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.02.006 · Cited by 20
Best Practices for Right Heart Catheterization in the Diagnosis of Pulmonary Hypertension
Matusov, Y. P., Kolaitis, N. A., Geft, D. R., DesJardin, J. T., Barnett, C. F., Hage, A., Marco, T. D., & Lewis, M. I. (2025) · CHEST Journal · doi:10.1016/j.chest.2025.05.009 · Cited by 20
Lee, M.-W., Ryu, H., Choi, Y., Song, I., Lee, H. J., Yun, H., Sun, B. J., Jeong, J., & Jo, D. (2020) · Blood Research · doi:10.5045/br.2020.2020001 · Cited by 20
Godinas, L., Iyer, K., Mészáros, G., Quarck, R. A., Subías, P. E., Noordegraaf, A. V., Jansa, P., D’Alto, M., Luknar, M., Ilic, S. M., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01752-1 · Cited by 20
Vrigκou, E., Vassilatou, E., Dima, E., Langleben, D., Kotanidou, Α., & Tzanela, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040921 · Cited by 20
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
Palassin, P., Maria, A. T. J., Ladhari, C., Quantin, X., Montani, D., BOURDIN, A. A., Boissin, C., Fesler, P., Hillaire‐Buys, D., Guilpain, P., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03208-2 · Cited by 20
Self-citationZhao, C., Hu, L., He, X., Li, L., Yin, M., Tettey, A. T., Wang, Y., Shen, J., Tang, S., Wu, C., et al. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107017 · Cited by 20
Deep Learning for Detection of Exercise-Induced Pulmonary Hypertension Using Chest X-Ray Images
Kusunose, K., Hirata, Y., Yamaguchi, N., Kosaka, Y., Tsuji, T., Kotoku, J., & Sata, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.891703 · Cited by 20
Abozeed, M., Conic, S., Bullen, J. A., Rizk, A. G., Saeedan, M. B., Karim, W., Heresi, G. A., & Renapurkar, R. D. (2022) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-21-686 · Cited by 20
Swisher, J. W., & Weaver, E. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s321025 · Cited by 20
Lanzarone, E., Baratto, C., Vicenzi, M., Villella, F., Rota, I., Dewachter, C., Muraru, D., Tomaselli, M., Gavazzoni, M., Badano, L. P., et al. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14436 · Cited by 20
Outcomes of pregnancy in women with different types of pulmonary hypertension
Liu, Y., Li, H., Li, Y., Zhang, J., Gu, H., Wang, J., & Wang, Q. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03423-4 · Cited by 20
Sahay, S., Lane, J. E., Sharpe, M. G., Toth, D., Paul, D., Siuba, M., & Tonelli, A. R. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202303-216oc · Cited by 20
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.